Jul
2026
QSNCC, Bangkok, Thailand
Visit us
stand E52

ENIMMUNE CORPORATION

Exhibitor at CPHI South East Asia 2026
About Us

ENIMMUNE focuses on clinical trials, new drug commercialization, and strategic partnerships with research-based pharmaceutical companies. By integrating resources across the pharmaceutical ecosystem, we accelerate the development and market access of innovative drugs and vaccines. Through technology transfer and collaboration with academia, research institutes, and clinical trial centers, we aim to address unmet medical needs and improve global health.

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • Country/Region:
    Taiwan
  • On CPHI since:
    2026
  • Employees:
    25 - 49
Company types
Biopharmaceutical company
Distributor/Import Export
View company profile
Contact info
  • 27001216
  • Website
  • 18th Floor, -2, No. 76, Section 2, Dunhua South Road, Da'an District, 106, Taipei, Taiwan
Show contact info Hide contact info
Event information
CPHI South East Asia 2026
  • 08 Jul 2026 - 10 Jul 2026
  • QSNCC, Bangkok, Thailand
  • Visit us at stand E52

Products Featured at CPHI South East Asia 2026

  • AdimFlu-S

    Product AdimFlu-S

    AdimFlu-S is an inactivated seasonal influenza vaccine developed by Adimmune Corporation for the prevention of influenza infection. The vaccine contains influenza virus strains recommended annually by the World Health Organization and is designed to provide protection against circulating influenza viruses....
  • EnVAX-A71

    Product EnVAX-A71

    EnVAX-A71 is an inactivated enterovirus A71 (EV-A71) vaccine developed for the prevention of EV71-associated hand, foot and mouth disease (HFMD) and herpangina in infants and young children. Manufactured using a bioreactor-based process, EnVAX-A71 demonstrated 99.21% vaccine efficacy in a multicenter Phase...
  • TETANUS TOXOID ALUM PRECIPITATED “KUO KWANG“

    Product TETANUS TOXOID ALUM PRECIPITATED “KUO KWANG“

    Tetanus Toxoid Alum Precipitated “KUO KWANG” is a sterile injectable vaccine indicated for active immunization against Tetanus. The vaccine contains purified tetanus toxoid adsorbed onto aluminum salts (alum) to enhance immunogenicity and induce protective antibody responses against the toxin produced by C...